Illustration by Eric Hanson

Notebooks

The Prize of RNAi

  • Wednesday, November 1, 2006
  • By Phillip Sharp

The recently discovered role of small RNAs could mean new drugs and a new understanding of fundamental biology.

   

Only eight years after their 1998 paper in Nature announced the discovery of RNA interference (RNAi), in which double-stranded RNA is used to silence genes, Andrew Fire and Craig Mello awoke in the wee hours of the morning of October 2 to the news that they were the 2006 recipients of the Nobel Prize in Physi­ology or Medicine. Such a short time between discovery and prize often signifies a finding's importance: it took only nine years for Watson and Crick to win the Nobel for discovering the structure of DNA. The Nobel Assembly's confidence in the importance of RNAi is obvious.

The initial experiment by Fire and Mello, showing that double-stranded RNA injected into worms would silence the gene with the corresponding sequence, was a clarion call to labs around the world, announcing a new method for investigating gene functions. After the initial discovery, other labs showed that small ­double-­stranded RNAs could be used to selectively silence genes in human cells, providing a much-sought-after general approach to exploring the functions of all 21,000 human genes.

 

To read the entire article you must log in:

Most of our content — all daily news, blogs, and videos — is free. Magazine stories are paid. To read this story, you must have a subscription or you must use a reading credit. Registration to Technology Review is free and entitles registrants to three free reading credits.

Username or REGISTER
Password  
   
 
Advertisement

MAGAZINE

Can We Build Tomorrow's Breakthroughs?

Manufacturing in the United States is in trouble. That's bad news not just for the country's economy but for the future of innovation.

Videos

Meet 2011 TR35 Winner Jesse Robbins

More

Advertisement

Technology Review Lists

TR50

Our list of the 50 most innovative companies, including the following:

Pacific Biosciences

First Solar

Novomer

Suntech

More

Advertisement

Facebook

Advertisement